Charlemagne Capital as of June 30, 2015
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 50 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Baidu (BIDU) | 18.6 | $20M | 102k | 199.85 | |
Mobile TeleSystems OJSC | 16.1 | $18M | 1.8M | 9.76 | |
Banco Itau Holding Financeira (ITUB) | 10.4 | $11M | 1.0M | 10.95 | |
AngloGold Ashanti | 9.0 | $9.9M | 1.1M | 8.99 | |
Jd (JD) | 4.9 | $5.3M | 16k | 336.96 | |
TAL Education (TAL) | 4.7 | $5.1M | 145k | 35.33 | |
Ambev Sa- (ABEV) | 4.2 | $4.7M | 765k | 6.09 | |
Fomento Economico Mexicano SAB (FMX) | 4.1 | $4.5M | 51k | 89.03 | |
Alibaba Group Holding (BABA) | 3.8 | $4.1M | 50k | 82.33 | |
Banco Bradesco SA (BBD) | 3.7 | $4.1M | 446k | 9.12 | |
Grupo Televisa (TV) | 2.8 | $3.0M | 78k | 38.83 | |
Credicorp (BAP) | 2.7 | $3.0M | 22k | 139.13 | |
BRF Brasil Foods SA (BRFS) | 2.7 | $2.9M | 141k | 20.92 | |
Companhia Brasileira de Distrib. | 1.7 | $1.8M | 78k | 23.61 | |
Luxoft Holding Inc cmn | 1.4 | $1.6M | 28k | 56.47 | |
Cemex SAB de CV (CX) | 1.4 | $1.5M | 165k | 9.15 | |
Nord Anglia Education | 1.2 | $1.3M | 54k | 24.54 | |
Copa Holdings Sa-class A (CPA) | 0.8 | $840k | 10k | 82.72 | |
Pfizer (PFE) | 0.6 | $622k | 19k | 33.56 | |
Ultrapar Participacoes SA (UGP) | 0.4 | $435k | 21k | 21.01 | |
Gilead Sciences (GILD) | 0.3 | $377k | 3.2k | 117.52 | |
Merck & Co (MRK) | 0.3 | $340k | 6.0k | 57.00 | |
Petroleo Brasileiro SA (PBR.A) | 0.3 | $333k | 41k | 8.17 | |
Thermo Fisher Scientific (TMO) | 0.2 | $262k | 2.0k | 129.70 | |
Grupo Financiero Galicia (GGAL) | 0.2 | $263k | 14k | 18.98 | |
Abbvie (ABBV) | 0.2 | $269k | 4.0k | 67.30 | |
Amgen (AMGN) | 0.2 | $251k | 1.6k | 153.70 | |
Banco Macro SA (BMA) | 0.2 | $252k | 5.5k | 45.86 | |
Cosan Ltd shs a | 0.2 | $241k | 39k | 6.15 | |
UnitedHealth (UNH) | 0.2 | $228k | 1.9k | 122.32 | |
CVS Caremark Corporation (CVS) | 0.2 | $217k | 2.1k | 104.93 | |
Illumina (ILMN) | 0.2 | $207k | 948.00 | 218.35 | |
Bristol Myers Squibb (BMY) | 0.2 | $202k | 3.0k | 66.62 | |
Medivation | 0.2 | $184k | 1.6k | 114.07 | |
Regeneron Pharmaceuticals (REGN) | 0.2 | $174k | 341.00 | 510.26 | |
Impax Laboratories | 0.2 | $181k | 3.9k | 45.83 | |
Becton, Dickinson and (BDX) | 0.1 | $149k | 1.1k | 141.90 | |
Amphastar Pharmaceuticals (AMPH) | 0.1 | $149k | 8.5k | 17.63 | |
Vale (VALE) | 0.1 | $145k | 25k | 5.85 | |
Boston Scientific Corporation (BSX) | 0.1 | $136k | 7.7k | 17.72 | |
Abbott Laboratories (ABT) | 0.1 | $115k | 2.3k | 49.17 | |
Celgene Corporation | 0.1 | $105k | 908.00 | 115.64 | |
Stryker Corporation (SYK) | 0.1 | $100k | 1.0k | 95.51 | |
Incyte Corporation (INCY) | 0.1 | $89k | 857.00 | 103.85 | |
Edwards Lifesciences (EW) | 0.1 | $93k | 654.00 | 142.20 | |
Aegerion Pharmaceuticals | 0.1 | $83k | 4.4k | 19.03 | |
Cardinal Health (CAH) | 0.1 | $82k | 981.00 | 83.59 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $67k | 5.6k | 12.01 | |
Quintiles Transnatio Hldgs I | 0.1 | $71k | 973.00 | 72.97 | |
Biogen Idec (BIIB) | 0.0 | $44k | 108.00 | 407.41 |